Intercell will purchase Cytos' technology for $20.1 million

05/6/2010 | Reuters

Intercell agreed to pay $20.1 million to acquire Cytos' technology platform designed to prevent and treat infectious diseases. The deal is expected to help Intercell develop therapies for hospital-acquired infections and other conditions.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA